Profile Solutions, Inc., through its subsidiary Elite Products International, Inc. is a leading distributor and manufacturer in the cannabinoid (CBD) industry. The Company’s products contain cutting-edge CBD Hemp extracts in the form of edibles, creams, oils, and salves. Additionally, the company developed and currently has working prototypes of a climate controlled positive identification secure depository. The CannaSafe is based on remote keyfob or fingerprint biometric access to the device. The Cannasafe was developed to store critical medications or valuables and keep them out of the reach of children or unauthorized access.
Profile Solutions Biometric Med Safe
The PROFILE Biometric Safe is a secure, affordable solution for protecting personal belongings or valuables with the touch of a finger. The PROFILE safe can be a floor or wall mounted solution, and can be utilized for residential, commercial or professional use. The product is designed as a secure storage device for critical medication, jewelry, weapons, documents, and other valuables or items that need to be secured.
The PROFILE Safe utilizes fingerprint recognition technology to allow access to only those whose fingerprints are registered. The PROFILE Safe is a standalone unit that includes all the electronics to allow a user to store, delete, and verify fingerprints with the use of a numeric keypad. Stored fingerprints are retained even in the event of power failure or battery drain.
Profile is entering the emerging Cannabis, Cannabinoid and Hemp market to distribute and manufacture cutting-edge Cannabis, Cannabinoid and Hemp extracts in the form of edibles, creams, oils, and salves for humans and pets.
Visit EliteHempProducts.com to learn more.
Profiles initial focus shall be Cannabinoid (“CBD”)
The content for this section will be: CBD is the part of the cannabis plant that doesn’t get you “high” like the THC side of the plant. CBD products are either derived from industrial hemp plants or marijuana plants. CBD is typically used for health reasons such as pain, stress and anxiety relief instead of for recreational purposes. According to a 2013 review published in the British Journal of Clinical Pharmacology, studies have found CBD to possess medical properties to act as an Analgesic, Anxiolytic, Anti-Depressant, Anti-inflammatory and others. The Hemp Business Journal estimated that the CBD market will grow to a $2.1 billion market in consumer sales by 2020 with $450 million of those sales coming from hemp-based sources, a 700% increase from 2016. In 2015, the market for consumer sales of hemp-derived CBD products was $90 million, plus another $112 million in marijuana-derived CBD products which were sold through dispensaries bringing a total CBD market to $202 million last year. Currently there are 29 states plus DC that have legalized medical marijuana including 8 states which have legalized recreational marijuana.
We intend to aggressively expand our operations by providing quality hemp-based products at affordable prices to satisfy the demand and requirements of our current and future clients